CCL20 and ovarian carcinoma: Recent research has shown that cisplatin-induced macrophages promote tumor progression and metastasis in ovarian cancer via the CCL20-CCR6 axis, which can be targeted therapeutically to reduce drug-induced metastasis in advanced-stage ovarian cancer [67].